News

Yet my experience is a blip among the millions of people with allergies in Australia. Around 5 million Australians live with ...
Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing ...